Health Triage strengthens its shareholder base: Vertis SGR and Health 1 enter the capital to support its oncology AI projects

The operation enables expansion into EU and US markets and the completion of the FDA process for Prostate V-Bio. The integration of new strategic partners consolidates the group’s clinical leadership in high-impact, technology-driven early diagnosis. NAPLES/TURIN, 2 July 2026 – Health Triage S.p.A., an Italian deep-tech company specialising in the development of Artificial Intelligence solutions…

Read more

Artificial Intelligence and Health: Piedmont Becomes a Global Hub for the Diagnostics of the Future

Monday, June 29, 2026, starting at 10:00 AM, the Romantic Hotel Furno in San Francesco al Campo will host the institutional conference “Artificial Intelligence: from radiology to global scenarios”, organized by the Centro Diagnostico Studio Futura of Ciriè and by Health Triage, under the patronage of Confindustria Canavese. The event was born to address an…

Read more

«Bringing artificial intelligence into the clinic. For real.»

Davide Dettori, CEO of Health Triage, is leading the development of AI for oncological diagnostics. From virtual biopsy to precision prevention, his goal is to bring validated technologies into global clinical practice. Bringing artificial intelligence into clinical practice is no longer a promise — it is a concrete challenge that requires scientific rigour, multidisciplinary integration…

Read more

Digital Europe 2026: Europe Funds Operational Clinical Pilots of AI in Medical Centers

The opening of the DIGITAL-2026-AI-PILOTING-10-SCREENING The opening of the DIGITAL-2026-AI-PILOTING-10-SCREENING call, with a total budget of €9 million, marks a concrete step in Europe’s strategy for artificial intelligence in healthcare: bringing imaging-based solutions directly into clinical settings, with a focus on early detection of cancer and cardiovascular disease — no longer just research, but operational…

Read more

The turning point of “Active Surveillance”

The recent update of the American Urological Association 2026 guidelines and the evidence presented at the EAU 2026 confirm a trend that may mark a clear boundary: the transition from a “linear” diagnostic approach to an advanced model of algorithm-assisted decision-making. This paradigm shift does not aim to replace the clinician’s judgment, but rather to…

Read more

Mammography screening: Swedish study in The Lancet confirms the effectiveness of Artificial Intelligence

The final results of the MASAI study, published in The Lancet and covered by major international media outlets such as The Guardian, mark a turning point in oncological diagnostics. The randomized trial, involving over 100,000 women in Sweden, demonstrates that integrating AI into the screening workflow is not only safe, but superior to traditional methods.…

Read more

Prostate cancer diagnosis: Health Triage in Florence for the Tuscan GOM network meeting.

On March 26–27, 2026, Health Triage will participate as a sponsor in the course “Diagnosis, Staging and Multidisciplinary Management of Prostate Cancer: The Tuscan GOM Network in Action.” The event, which will take place at the Grand Hotel Mediterraneo in Florence, represents a strategic opportunity for discussion among coordinators of regional oncology networks, aimed at…

Read more